サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ATPアッセイの世界市場-2022-2029
市場調査レポート
商品コード
1129274

ATPアッセイの世界市場-2022-2029

Global ATP assays Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ATPアッセイの世界市場-2022-2029
出版日: 2022年09月29日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

様々な産業でRapid ATP生物発光アッセイの採用が進んでいることが、予測期間中の原動力になると予想されます。

迅速ATP生物発光検査は、製薬、バイオテクノロジー、ヘルスケア、飲食品産業など、多くの最終使用産業で広く使用されています。これらの検査は、食品や医薬品のサンプルに含まれる微生物の数を正確に測定し、さまざまな表面の汚れや汚染物質の量を評価します。さらに、迅速ATP生物発光アッセイの需要は、院内感染率の上昇、高度な除菌技術の採用の増加、公衆衛生および衛生に関する取り組みの増加、微生物汚染を検出するための水処理および廃水処理プラントにおけるATPアッセイの使用の増加によって牽引されてきました。したがって、上記の記述から、予測期間中に市場が促進されると予想されます。

制約事項

機器のコストが高いこと、細胞外ATPと細胞内ATPを区別できないことなどが、予測期間中に市場が阻害される要因の1つであると考えられています。

産業分析

ATPアッセイ市場は、ポーターファイブフォース、サプライチェーン、価格分析などの様々な産業要因に基づいた市場の詳細な分析を提供します。

COVID-19の影響分析

COVID-19のパンデミックは、市場にプラスの影響を与えています。パンデミック時のワクチン製造のため、COVID-19研究用の細胞培養液の使用量が増加しました。製薬会社、バイオテクノロジー企業、研究機関、大学機関は、ほとんど影響を受けずに重要なワクチン関連研究を行っています。COVID-19については、すでにいくつかのワクチンや抗ウイルス薬が承認され、あるいは作られつつあります。このため、製薬会社や医療現場で表面や器具の除染に使用されるATPアッセイなどの細胞アッセイ製品の需要が高まっています。さらに、医薬品やワクチンの開発におけるセルベースアッセイの需要の増加、承認された医薬品や生物製剤の数、臨床試験全体、製薬会社の研究開発費の伸びによる生物製剤市場の拡大などは、ATPアッセイの使用量の増加を予想させるものです。したがって、上記の記述から、市場は予測期間を押し上げると予想されます。

当レポートでは、45以上の市場データ表、40以上の図表、180ページにわたる情報を提供しています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

  • 市場影響要因
    • 促進要因
      • Rapid ATP Bioluminescence assayの様々な産業での採用が進み、予測期間中に市場を牽引すると予想されます。
    • 抑制要因
      • 装置のコスト高が予測期間中の阻害要因となる見込み。
    • 市場機会
    • 影響分析

第5章 産業分析

  • ポーターの5つの力
  • アンメットニーズ
  • サプライチェーン
  • プライシング分析

第6章 COVID-19分析

  • COVID-19の市場分析
    • COVID-19発売前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • まとめ

第7章 製品タイプ別

  • 消耗品・アクセサリー
    • 試薬・キット
    • マイクロプレート
    • その他
  • 測定機器
      • ルミノメータ
      • 分光光度計

第8章 アプリケーション別

  • コンタミネーション検査
  • 疾患検査
  • 創薬・医薬品開発
  • その他

第9章 エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 飲食品業界
  • 病院・診断機関
  • 学術・研究機関
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第12章 企業プロファイル

  • Thermo Fisher Scientific, Inc.
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Promega Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Abcam plc
  • Lonza Group
  • 3M
  • Xylem
  • Geno Technology Inc.

第13章 ATPアッセイの世界市場-DataM

目次
Product Code: DMBT5850

Market Overview

ATP Assays Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY % during the forecast period (2022-2029).

ATP or Adenosine triphosphate is an organic substance that is the main energy source in all living things and powers various biological functions like nerve impulse transmission, muscular contraction, and chemical synthesis. Since the presence of ATP influences a cell's viability, the concentration of ATP directly correlates with the number of active cells. Cell viability is measured, and bacteria and other microbes are found using ATP assays, which are ATP detection techniques. The fluorescent, bioluminescent, and colorimetric ATP tests are the most widely used ATP assays. Due to its better practicality, increased sensitivity, homogeneous technique, and quick results, bioluminescent ATP assays are the most optimal. These tests are widespread in diagnostic labs, hospitals, and research labs. They are also widely used in the food and beverage industry to determine the cleanliness and safety of food or liquid samples. As they are better at identifying the overall microbial content of samples, ATP assays are now increasingly favored over traditional culture-based diagnostics. A few benefits of ATP tests include quick testing and monitoring, increased sensitivity, and quicker, more precise results.

Market Dynamics

The rising adoption of Rapid ATP bioluminescence assays in various industries is expected to drive in the forecast period.

Rapid ATP bioluminescence tests are widely used across many end-use industries, including the pharmaceutical, biotechnology, healthcare, and food & beverage industries. These tests accurately determine the number of microorganisms in food and medicine samples and evaluate the amount of dirt or contaminants on different surfaces. Moreover, the demand for quick ATP bioluminescence assays has been driven by the rising rate of hospital-acquired infections, increasing adoption of advanced sanitization techniques, increasing public health & hygiene initiatives, and growing use of ATP assays in water and wastewater treatment plants to detect microbial contamination. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

The high cost of the instruments, the inability to differentiate between extracellular and intracellular ATP are some of the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The ATP assays market provides in-depth analysis of the market based on various industry factors such as porter five forces, supply chain, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has positively impacted the market. Cell culture media use for COVID-19 research has increased due to the manufacturing of vaccines during pandemics. Pharmaceutical and biotechnology firms, research institutes, and university institutions conduct critical vaccine-related research with largely unaffected operations and output. For COVID-19, several vaccines or antiviral medications have already received approval or are being created. This has raised the demand for cell assay products like ATP assays used in pharmaceutical firms and medical settings to decontaminate surfaces and equipment. Moreover, the increased demand for cell-based assays in developing pharmaceuticals and vaccines, the number of approved medications and biologics, overall clinical trials, and the expanding biologics market with the growth in pharma R&D spending all point to an expected increase in the usage of ATP assays. Thus, from the above statements, the market is expected to boost the forecast period.

Segment Analysis

Consumables & Accessories segment is expected to hold the largest market share in ATP assays market.

The consumables & accessories segment accounted for the largest market share in 2021. The segment is sub-segmented into reagents & kits, microplates, and other consumables & accessories. Moreover, the segment is benefited from the widespread use of ATP assays in research facilities to assess cell viability, the rise in drug discovery brought on by the prevalence of chronic diseases that necessitate tumor testing and cell proliferation (in cancer), and the regular expenditure of funds by pharmaceutical and biotechnology firms on consumables. Therefore, it has increased the adoption of the ATP assays consumables & accessories.

Geographical Analysis

North America region holds the largest market share in the global ATP assays market

In 2021, the North American ATP assays accounted for the highest revenue share in the global market. The increasing prevalence of chronic diseases like cancer, rising cases of coronavirus in the region, presence of large pharmaceutical & biotechnology industries, rising demand for cell-based assays in research and rising funding for drug development by the marker players are the factors the market is expected to boost in the forecast period. For instance, according to the American Cancer Society, In 2020, an estimated 1.8 million new cancer cases and 606,520 cancer deaths in the United States will be diagnosed. In contrast, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Moreover, With a combined expenditure of USD 44.2 million (EUR 40 million) at its manufacturing plants in Danvers, Massachusetts, and Jaffrey, New Hampshire, Merck expanded its manufacturing footprint in 2020. These websites offer vital products to clients creating life-saving medications, such as COVID-19 vaccinations, as well as goods and services for the production of biopharmaceuticals. Therefore, it has increased the demand for the ATP assays, and thus the North American region accounted for the largest market share.

Competitive Landscape

Major key players in the ATP assays market are Thermo Fisher Scientific, Inc., Promega Corporation, Merck KGaA, PerkinElmer, Inc., Agilent Technologies, Inc., Abcam plc, Lonza Group, 3M, Xylem, Geno Technology Inc.

Thermo Fisher Scientific, Inc.:

Overview:

Thermo Fisher Scientific is an American company incorporated in 1956 and based in Waltham, Massachusetts. The company offers worldwide life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services. Moreover, the global team has more than 90,000 colleagues who deliver an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Product Portfolio:

Invitrogen ATP Determination Kit: Molecular Probes ATP Determination Kit offers a convenient bioluminescence assay for quantitatively determining ATP with recombinant firefly luciferase and its substrate D-luciferin. This sensitivity has led to numerous applications for detecting ATP production in various enzymatic reactions, including ATPase and NADPH oxidase, as well as for detecting low-level bacterial contamination in samples such as blood, milk, urine, soil and sludge. The luciferin-luciferase bioluminescence assay has also been used successfully to study the effects of antibiotics on bacterial populations, to determine cell proliferation and cytotoxicity in both bacterial and mammalian cells, and to distinguish cytostatic versus the cytocidal potential of anticancer drugs on malignant cell growth.

The global ATP assays market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising adoption of Rapid ATP bioluminescence assays in various industries is expected to drive in the forecast period.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of the instruments is expected to get hampered in the forecast period.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply Chain
  • 5.4. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Consumables & Accessories
      • 7.2.1.1. Reagents & Kits
      • 7.2.1.2. Microplates
      • 7.2.1.3. Others
      • 7.2.1.3.1. Introduction
      • 7.2.1.3.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Instruments
      • 7.3.1.1. Luminometers
      • 7.3.1.2. Spectrophotometers

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application Segment
  • 8.2. Contamination Testing*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Disease Testing
  • 8.4. Drug Discovery and Development
  • 8.5. Others

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user Segment
  • 9.2. Pharmaceutical & Biotechnology companies*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Food and Beverage Industry
  • 9.4. Hospitals and Diagnostic Laboratories
  • 9.5. Academic and Research Institutions
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Thermo Fisher Scientific, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Promega Corporation
  • 12.3. Merck KGaA
  • 12.4. PerkinElmer, Inc.
  • 12.5. Agilent Technologies, Inc.
  • 12.6. Abcam plc
  • 12.7. Lonza Group
  • 12.8. 3M
  • 12.9. Xylem
  • 12.10. Geno Technology Inc.

LIST NOT EXHAUSTIVE

13. Global ATP assays Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us